United States 116th Congress Status: Died 1 R cosponsors

HR 7661 — Coronavirus EGC Extension Act

Last action — Referred to the House Committee on Financial Services.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. Died in session

This bill died with 116th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Extends the status of an issuer of securities as an emerging growth company. Specifically, these issuers will remain emerging growth companies until the later of one year after the date of enactment of this bill, the end of the COVID-19 (i.e., coronavirus disease 2019) emergency declaration period, and the date the issuer would otherwise cease being an emerging growth company. Emerging growth companies (in general, a newly public company with revenues below a specified threshold) are subject to reduced disclosure requirements, among other regulations.

Bill Text

We don't have the full text on file for this bill yet.

Read HR 7661 on the official United States source →

Action History

  1. Referred to the House Committee on Financial Services.

  2. Introduced in House

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 546 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (546)

546 members have not signed on to this bill.

Show all 546 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Finance and financial sector Accounting and auditing Business investment and capital Cardiovascular and respiratory health Corporate finance and management Emergency medical services and trauma care Government information and archives Infectious and parasitic diseases Securities Small business Wages and earnings
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HR 7661 do?
Extends the status of an issuer of securities as an emerging growth company. Specifically, these issuers will remain emerging growth companies until the later of one year after the date of enactment of this bill, the end of the COVID-19 (i.e., coronavirus disease 2019) emergency declaration period, and the date the issuer would otherwise cease being an emerging growth company. Emerging growth companies (in general, a newly public company with revenues below a specified threshold) are subject to reduced disclosure requirements, among other regulations.
Who sponsors HR 7661?
HR 7661 is sponsored by Bryan Steil (R).
What is the current status of HR 7661?
This bill died with 116th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HR 7661?
Track HR 7661 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HR 7661

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HR 7661

Last checked for changes about 15 hours ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →